Logo Logo
Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Jump to: 2017 | 2016 | 2011
Number of items: 3.


Weis, C.; Prada, Aristizabal E. T.; Maurer, J.; Spöttl, G.; Grossman, A.; Auernhammer, C. J.; Noelting, S. (2017): GSK3: A Novel Therapeutic Target in NETs? In: Neuroendocrinology, Vol. 105: p. 227


Noelting, S.; Rentsch, J.; Freitag, H.; Briest, F.; Schrader, J.; Koenig, A.; Prada, Aristizabal E. T.; Siegmund, B.; Auernhammer, C. J.; Grabowski, P. (2016): Selective Inhibition of PI3Kalpha (BYL719) - Promising Therapeutic Option for Neuroendocrine Tumors? In: Neuroendocrinology, Vol. 103: p. 4


Zitzmann, K.; de Toni, E.; Ruden, J. von; Brand, S.; Göke, Burkhard; Laubender, Rüdiger P.; Auernhammer, C. J. (2011): The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. In: Endocrine-Related Cancer, Vol. 18, No. 2: pp. 277-285

This list was generated on Wed May 22 05:00:18 2019 CEST.